Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yallaferon in HPV Infection
NCT01824992Phase 3Completed
- Sponsor
- Lee's Pharmaceutical Holdings Limited
- Start
- Mar 2011
- Primary completion
- Mar 2012
- Modality
- Cytokines & Interferons
01
Overview
A Phase 3 trial of interferon alfa-2b in human papillomavirus infection, sponsored by Lee's Pharmaceutical Holdings Limited. Started Mar 2011; status: completed.
02
Drugs
interferon alfa-2b
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT01824992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01824992.